172 related articles for article (PubMed ID: 36795892)
21. Lentivirus-Mediated Short Hairpin RNA for Follistatin Downregulation Suppresses Tumor Progression in Hypopharyngeal Carcinoma.
Ge L; Liu SF
Curr Med Sci; 2022 Aug; 42(4):832-840. PubMed ID: 35864413
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.
Ricciardelli C; Ween MP; Lokman NA; Tan IA; Pyragius CE; Oehler MK
BMC Cancer; 2013 Oct; 13():476. PubMed ID: 24124770
[TBL] [Abstract][Full Text] [Related]
23. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
24. Chemoresistance is mediated by ovarian cancer leader cells in vitro.
Karimnia N; Wilson AL; Green E; Matthews A; Jobling TW; Plebanski M; Bilandzic M; Stephens AN
J Exp Clin Cancer Res; 2021 Sep; 40(1):276. PubMed ID: 34470672
[TBL] [Abstract][Full Text] [Related]
25. Follistatin promotes adipocyte differentiation, browning, and energy metabolism.
Braga M; Reddy ST; Vergnes L; Pervin S; Grijalva V; Stout D; David J; Li X; Tomasian V; Reid CB; Norris KC; Devaskar SU; Reue K; Singh R
J Lipid Res; 2014 Mar; 55(3):375-84. PubMed ID: 24443561
[TBL] [Abstract][Full Text] [Related]
26. Follistatin is an early player in rainbow trout ovarian differentiation and is both colocalized with aromatase and regulated by the wnt pathway.
Nicol B; Yano A; Jouanno E; Guérin A; Fostier A; Guiguen Y
Sex Dev; 2013; 7(5):267-76. PubMed ID: 23615022
[TBL] [Abstract][Full Text] [Related]
27. AAV2-mediated follistatin overexpression induces ovine primary myoblasts proliferation.
Nazari M; Salabi F; Zhang L; Zhao F; Wei C; Du L
BMC Biotechnol; 2014 Oct; 14():87. PubMed ID: 25330993
[TBL] [Abstract][Full Text] [Related]
28. Cross‑validation of genes potentially associated with neoadjuvant chemotherapy and platinum‑based chemoresistance in epithelial ovarian carcinoma.
Zhang K; Wang W; Chen L; Liu Y; Hu J; Guo F; Tian W; Wang Y; Xue F
Oncol Rep; 2020 Sep; 44(3):909-926. PubMed ID: 32705213
[TBL] [Abstract][Full Text] [Related]
29. Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.
Song J; Shih IeM; Chan DW; Zhang Z
Neoplasia; 2009 Jun; 11(6):605-14, 1 p following 614. PubMed ID: 19484149
[TBL] [Abstract][Full Text] [Related]
30. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
[TBL] [Abstract][Full Text] [Related]
31. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells.
Sun H; Wang H; Wang X; Aoki Y; Wang X; Yang Y; Cheng X; Wang Z; Wang X
Theranostics; 2020; 10(15):6928-6945. PubMed ID: 32550913
[No Abstract] [Full Text] [Related]
32. Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.
Pan WW; Zhou JJ; Liu XM; Xu Y; Guo LJ; Yu C; Shi QH; Fan HY
J Biol Chem; 2013 May; 288(19):13620-30. PubMed ID: 23539629
[TBL] [Abstract][Full Text] [Related]
33. MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway.
Gu ZW; He YF; Wang WJ; Tian Q; Di W
J Zhejiang Univ Sci B; 2019 Mar.; 20(3):219-237. PubMed ID: 30829010
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.
Zhang K; Erkan EP; Jamalzadeh S; Dai J; Andersson N; Kaipio K; Lamminen T; Mansuri N; Huhtinen K; Carpén O; Hietanen S; Oikkonen J; Hynninen J; Virtanen A; Häkkinen A; Hautaniemi S; Vähärautio A
Sci Adv; 2022 Feb; 8(8):eabm1831. PubMed ID: 35196078
[TBL] [Abstract][Full Text] [Related]
35. Nucleolar follistatin promotes cancer cell survival under glucose-deprived conditions through inhibiting cellular rRNA synthesis.
Gao X; Wei S; Lai K; Sheng J; Su J; Zhu J; Dong H; Hu H; Xu Z
J Biol Chem; 2010 Nov; 285(47):36857-64. PubMed ID: 20843798
[TBL] [Abstract][Full Text] [Related]
36. Follistatin Protects Against Glomerular Mesangial Cell Apoptosis and Oxidative Stress to Ameliorate Chronic Kidney Disease.
Mehta N; Gava AL; Zhang D; Gao B; Krepinsky JC
Antioxid Redox Signal; 2019 Sep; 31(8):551-571. PubMed ID: 31184201
[No Abstract] [Full Text] [Related]
37. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
38. Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells.
Huang KC; Yang J; Ng MC; Ng SK; Welch WR; Muto MG; Berkowitz RS; Ng SW
Eur J Cancer; 2016 Nov; 67():152-163. PubMed ID: 27669502
[TBL] [Abstract][Full Text] [Related]
39. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
Zou W; Ma X; Hua W; Chen B; Cai G
Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
[TBL] [Abstract][Full Text] [Related]
40. MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b.
Wang J; Da C; Su Y; Song R; Bai Z
Biochem Biophys Res Commun; 2021 Jun; 556():31-38. PubMed ID: 33836345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
